Authors
Latest:
How person-centered trial design improves clinical researchLearn how to develop and market products and interventions that actually meet individuals' needs by incorporating patient input exist throughout the trial lifecycle
Latest:
Solutions to Accelerate Data-Driven Chemicals and Materials InnovationTeams need to keep close track of ingredients, processing parameters, and material performance so that they can use their R&D data to decide exactly which materials to make next.
Latest:
Evaluating Global Regulatory Landscape for Driving Digital Innovation in Supply ManagementRecent updates from regulatory bodies are providing more confidence in integrating different forms of trials and technology.
Latest:
How Sponsors Can Use Health Decision Science to Improve Clinical Trial Recruitment and RetentionExamining the behaviors of clinical trial stakeholders to better understand challenges in patient participation.
Latest:
Executing Trial Design With Patients—Not For PatientsApproaching protocol design and operational planning with patient empathy.
Latest:
Importance of Diversity in Parkinson’s ResearchEliminating barriers to engage underrepresented populations.
Latest:
FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug DevelopersJanuary 2023 guidance from FDA on dosages in oncology provides further context on expectations with Project Optimus.
Latest:
What the Future of Study Review Processes Should Look LikeInsights from Bayer’s study review process showcases importance of incorporating feedback from a wider audience of stakeholders.
Latest:
Generational Differences Among African Americans, Their Experiences with the Healthcare SystemA study exploring healthcare preference and experience in this population group uncovers new insights and opportunities related to clinical research participation.
Latest:
Sharing Anonymized and Functionally Effective (SAFE) Data Standard for Safely Sharing Rich Clinical Trial DataPresenting how data transformation is measured as part of the SAFE Data Standard, which data variables influence the rating and, how the appropriate level of data transformation is calculated.
Latest:
Clinical Trials Diversity and InclusionChairman and Founder of MJH Life Sciences, Mike Hennessy Sr. explores the main discussion points covered in the June issue of ACT.
Latest:
Addressing the Needs of Clinical Trial Sites in a Post-COVID-19 WorldRecognizing pre-pandemic pain points, such as patient engagement and protocol development, could lead to post-pandemic trial success.
Latest:
Effective regulatory strategies for rare diseaseIn the rare disease issue of New Medicines, Novel Insights from Parexel, experts and former regulators share insights for developing effective regulatory strategies earlier.
Latest:
Targeting Patient PopulationKeys to ensuring your clinical trials better reflect your target population.
Latest:
Budgets and Billing in Clinical Trials: DCT ConsiderationsCost strategies for medical device trials in the new era of digital health.
Latest:
Precision Medicine in Clinical Trials: Adapting to the New Demands of Clinical Research TodayWebinar Date/Time: Thursday, May 25th, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Latest:
De-Risking Trials with Science-Driven OversightIdentifying the ‘significant six’ areas of clinical study conduct to mitigate risk.
Latest:
Post-Pandemic: An Argument for Protocol SimplicityWhat does the industry have to lose in pursuing a more straightforward path?
Latest:
AI/ML Approaches to Assisted Medical Writing—Part 2Following a discussion around summarization in Part 1, Part 2 discusses the method of pure abstraction in light of recent advances in deep learning and AI.
Latest:
Breathing New Life into Respiratory Clinical Trials with Digital BiomarkersIncreased data output from the use of devices can accelerate trials for this therapeutic area in need of new therapies.
Latest:
How to Measure Your Patient-Centric ImpactPractical suggestions for identifying what actionable insights have been impactful on clinical studies.
Latest:
How Reverse-Engineering Clinical Trials to Leverage the AI-based-Digital Twin Solution Solves for Many Current IssuesThese devices can help researchers identify data points that are not immediately available to researchers.
Latest:
Accelerating Innovation Adoption to Support Drug Development OperationsCharacterizing the long-term adoption experience of clinical technologies and capabilities—and what senior leaders can do to drive adoption within their walls.
Latest:
Expanding Conceptual Model of Disease into Conceptual Model of Patient Experience for Designing, Interpreting Medication EffectsA three-part framework for a more comprehensive conceptual model of patient experience data can provide a more rounded understanding of patient experiences in clinical trials and beyond.
Latest:
Modal Value Guided Clinical Trial Design Effectively Reduces Protocol AmendmentsAnalysis of 330,000 clinical trials calls for improved protocol design process.
